257 publications
Tezacaftor/ivacaftor (Symkevi®) with ivacaftor monopreparation (Kalydeco®) for the treatment of cystic fibrosis
Zorginstituut Nederland carried out an assessment in relation to extending the specific conditions for the medicinal product ...
Assessment of 'established medical science and medical practice’ - a technical modification
This report is a supplement to the existing Dutch assessment framework dating form 2015. It can be used to investigate whether an ...
Brexpiprazole (Rxulti®) for the treatment of schizophrenia in adults
Zorginstituut Nederland carried out a marginal assessment whether the product brexpiprazole (Rxulti®) can be accepted into the ...
Pitolisant (Wakix®) for the treatment of narcolepsy in adults
Zorginstituut Nederland carried out a marginal assessment whether pitolisant (Wakix®) is interchangeable with a drug currently ...
Glycopyrronium bromide (Sialanar®) for the symptomatic treatment of severe sialorrhoea
Zorginstituut Nederland carried out an assessment whether the product glycopyrronium bromide (Sialanar®) is interchangeable with ...
Tolvaptan (Jinarc ®) for the treatment of chronic kidney disease - alteration of the specific conditions
Zorginstituut Nederland carried out an assessment whether the specific conditions for tolvaptan (Jinarc ®) can be altered. ...
Durvalumab (Imfinzi®) for the treatment of locally advanced, unresectable, non-small cell lung cancer
Zorginstituut Nederland has completed its assessment of durvalumab (Imfinzi®) as monotherapy for the treatment of locally ...
Organisation structure National Health Care Institute
Amendment of the conditional inclusion of the medicine Fingolimod (Gilenya®) for the treatment of relapsing remitting multiple sclerosis (RRMS)
Zorginstituut Nederland carried out an assessment in relation to extending the specific conditions for the medicinal product ...
Abemaciclib (Verzenios®) for the treatment of metastatic breast cancer
Zorginstituut Nederland has completed its assessment of abemaciclib (Verzenios®) for the treatment of metastatic breast cancer. ...